ASF1B promotes gastric cancer progression by modulating H2AC20 and activating PI3K/AKT and ERK1/2 pathways
ASF1B, recognized as an oncogene, contributes to the initiation and progression of tumors, positioning it as a prospective target for therapeutic intervention in GC.
Authors
- Yanjun He (ORCID: https://orcid.org/0000-0002-8676-5893)
- Mengyuan Zhao (ORCID: https://orcid.org/0000-0002-8917-0780)
- Junchang Zhang (ORCID: https://orcid.org/0000-0002-5110-9546)
- Chongge You (ORCID: https://orcid.org/0000-0002-3671-596X)
Institutions
- Shandong Provincial Hospital (CN)
- Lanzhou University Second Hospital (CN)
- Shandong First Medical University (CN)
- Lanzhou University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-02-18
- DOI
- https://doi.org/10.3389/fphar.2025.1533257
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Natural Science Foundation of Gansu Province